LPL Financial’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$440K Sell
7,478
-21,175
-74% -$1.29M ﹤0.01% 5207
2026
Q2
$1.63M Buy
28,653
+14,999
+110% +$665K ﹤0.01% 3982
2026
Q1
$406K Buy
13,654
+4,130
+43% +$123K ﹤0.01% 4956
2025
Q4
$364K Buy
+9,524
New +$310K ﹤0.01% 4991

Other funds holding TVTX

LPL Financial's TVTX Position: Q3 2026 in Review

LPL Financial reduced its Travere Therapeutics (TVTX) stake by 74% in Q3 2026, selling an estimated $1.29M and leaving 7,478 shares worth $440K. The position accounts for ﹤0.01% of the portfolio, ranked #5207.

LPL Financial first reported a position in TVTX in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.63M in Q2 2026. 345 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.

  • LPL Financial held 7,478 shares of Travere Therapeutics worth $440K as of Q3 2026.
  • LPL Financial sold 21,175 Travere Therapeutics shares in Q3 2026, an estimated $1.29M.
  • Travere Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #5207 holding.
  • LPL Financial first reported a position in Travere Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • LPL Financial's Travere Therapeutics position peaked at $1.63M in Q2 2026.
  • 345 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.

Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.